Approximately 15% of newly diagnosed invasive breast cancer cases lack estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [1]. The gene discussed is ERBB2; the disease is invasive breast carcinoma.